Highlights WntResearch AB

Equities

WNT

SE0022239901

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
10.36 ^SEK	+11.04%		+54.63%	+12.61%

05-03	WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-03	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
WntResearch Initiates Collaboration with Business Sweden with the Goal of Establishing Commercial Partnerships for Foxy-5 in Japan and South Korea	02-26	CI
WntResearch AB Continues to the Next Step in the Phase 2 Study Neofox with the Highest Evaluated Dose of Foxy-5	02-12	CI
WntResearch Continues to the Second Dose Group in Clinical Proof of Concept Study of Foxy-5	12-06	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
WntResearch AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
WntResearch AB Announces New Study Plan Approves for Wnt Research's Phase II Study	23-07-14	CI
WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-09	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-09	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
WntResearch AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI
WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-05	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-09	CI
WntResearch files a patent application for the treatment of Acute Myeloid Leukemia	21-12-13	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-17	CI
WntResearch AB Announces Update on Patient Recruitment for the Ongoing Phase IIa Clinical Study Neofox with Wntresearch's Drug Candidate Foxy-5	21-04-14	CI
Wntresearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights WntResearch AB

Equities

WNT

SE0022239901

Highlights

Filters